| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 92,5 M € | +6.8% | 86,6 M € | -5.2% | 91,4 M € | -6.3% | 97,5 M € | -18.0% | 119,0 M € | +31.0% | 90,9 M € | +20.3% | 75,5 M € | +6.5% | 70,9 M € | -1.8% | 72,2 M € | +0.9% | 71,5 M € | +2.6% | 69,7 M € | +7.5% | 64,9 M € | +4.4% | 62,2 M € | +3.7% | 59,9 M € | +14.0% | 52,6 M € | +1.8% | 51,7 M € | -2.3% | 52,9 M € | +36.4% | 38,8 M € | |
| EBITDA | 20,4 M € | -29.6% | 29,0 M € | -15.5% | 34,4 M € | -6.3% | 36,7 M € | -22.1% | 47,1 M € | +65.9% | 28,4 M € | +11.6% | 25,4 M € | +9.7% | 23,2 M € | -7.4% | 25,0 M € | -1.8% | 25,5 M € | -22.6% | 32,9 M € | +6.2% | 31,0 M € | +6.1% | 29,2 M € | +9.2% | 26,7 M € | +32.4% | 20,2 M € | -2.7% | 20,8 M € | -6.2% | 22,1 M € | +62.9% | 13,6 M € | |
| Operating profit | 20,1 M € | -30.4% | 28,8 M € | -15.7% | 34,2 M € | -5.3% | 36,1 M € | -21.9% | 46,3 M € | +67.3% | 27,7 M € | +12.4% | 24,6 M € | +14.0% | 21,6 M € | -6.1% | 23,0 M € | -1.3% | 23,3 M € | -23.9% | 30,6 M € | +8.1% | 28,3 M € | +6.5% | 26,6 M € | +10.9% | 23,9 M € | +40.7% | 17,0 M € | -2.4% | 17,4 M € | -5.7% | 18,5 M € | +67.6% | 11,0 M € | |
| Profit/loss | 15,1 M € | -43.0% | 26,5 M € | +3.7% | 25,6 M € | -5.2% | 27,0 M € | -21.9% | 34,5 M € | +104.8% | 16,8 M € | +6.6% | 15,8 M € | -38.1% | 25,5 M € | +68.3% | 15,2 M € | -7.3% | 16,4 M € | -23.7% | 21,5 M € | +11.8% | 19,2 M € | +1.8% | 18,9 M € | +8.8% | 17,3 M € | +43.1% | 12,1 M € | +1.7% | 11,9 M € | -0.8% | 12,0 M € | +67.7% | 7,2 M € | |
| Equity | 6,5 M € | +1.5% | 6,4 M € | +30.7% | 4,9 M € | -8.4% | 5,3 M € | +124.7% | 2,4 M € | -17.5% | 2,9 M € | -93.6% | 45,3 M € | -37.5% | 72,5 M € | -55.2% | 161,9 M € | +10.3% | 146,7 M € | +10.9% | 132,4 M € | +16.7% | 113,4 M € | +20.4% | 94,2 M € | +22.4% | 77,0 M € | +24.8% | 61,7 M € | +20.3% | 51,2 M € | +30.3% | 39,3 M € | +44.0% | 27,3 M € | |
| Total assets | 44,4 M € | +9.1% | 40,7 M € | +0.9% | 40,3 M € | +5.1% | 38,4 M € | -20.4% | 48,2 M € | +74.8% | 27,6 M € | -50.6% | 55,8 M € | -29.1% | 78,7 M € | -53.5% | 169,3 M € | +4.2% | 162,5 M € | +16.3% | 139,8 M € | +16.8% | 119,7 M € | +19.0% | 100,6 M € | +20.4% | 83,5 M € | +24.5% | 67,1 M € | +20.9% | 55,5 M € | +26.5% | 43,9 M € | +38.3% | 31,7 M € | |
| Cash | 16,2 M € | -42.6% | 28,2 M € | +34.7% | 20,9 M € | -3.8% | 21,7 M € | +189.9% | 7,5 M € | +9.2% | 6,9 M € | -71.7% | 24,3 M € | -12.6% | 27,7 M € | -49.4% | 54,9 M € | +73.5% | 31,6 M € | +336.4% | 7,2 M € | +23.7% | 5,9 M € | -71.3% | 20,4 M € | -46.5% | 38,1 M € | +398.3% | 7,6 M € | -75.8% | 31,6 M € | +110.5% | 15,0 M € | +529.4% | 2,4 M € | |
| Debts | 38,0 M € | +10.6% | 34,3 M € | -3.1% | 35,4 M € | +7.2% | 33,0 M € | -28.0% | 45,9 M € | +85.5% | 24,7 M € | +134.6% | 10,5 M € | +69.9% | 6,2 M € | -15.6% | 7,3 M € | -53.3% | 15,7 M € | +114.4% | 7,3 M € | +17.1% | 6,3 M € | -0.8% | 6,3 M € | -2.5% | 6,5 M € | +18.8% | 5,5 M € | +28.0% | 4,3 M € | -6.2% | 4,5 M € | +3.0% | 4,4 M € | |
| Staff | 221,9 | 225,8 | 234,9 | 237,4 | 242,6 | 232,3 | 229,2 | 224,1 | 222,4 | 217,3 | 220,1 | 216,3 | 212,7 | 206,2 | 204,6 | 210,7 | 222,7 | 169,3 | ||||||||||||||||||
Private limited company · Herentals · incorporated on 27/06/1989 · 221,9 ETP
Private limited company profitable but thinly capitalised. Cash position declining (-42.6%).
Solid counterparty for a standard engagement.
CENTRUM VOOR MEDISCHE ANALYSE is a Private limited company incorporated in 1989. Its main activity is: Pre-primary education. Its registered office is in Herentals. It employs on average 221,9 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette